Cargando…
SARS-CoV-2 vaccination, ABO blood group and risk of COVID-19: population-based cohort study
OBJECTIVE: To compare outcomes between O and non-O blood groups, and by modified RNA (mRNA) and adenovirus-vectored (Ad-V) vaccines. DESIGN: Population-based cohort study. SETTING: All of Ontario, Canada. Linked data sets captured clinical encounters, vaccinations and laboratory testing for SARS-CoV...
Autores principales: | Ray, Joel G, Park, Alison L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297000/ https://www.ncbi.nlm.nih.gov/pubmed/35851010 http://dx.doi.org/10.1136/bmjopen-2021-059944 |
Ejemplares similares
-
Cohort Profile:The Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 vaccines (ENFORCE)
por: Stærke, Nina Breinholt, et al.
Publicado: (2022) -
ABO Blood Group, SARS-CoV-2 Infection, and Risk of Venous Thromboembolism: Population-Based Cohort Study
por: Ray, Joel G., et al.
Publicado: (2021) -
Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait
por: Alhaddad, Fatemah, et al.
Publicado: (2022) -
Kidney Transplant Recipient Attitudes Toward a SARS-CoV-2 Vaccine
por: Ou, Michael T., et al.
Publicado: (2021) -
Patient factors associated with SARS‐CoV‐2 in an admitted emergency department population
por: Haimovich, Adrian D., et al.
Publicado: (2020)